By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Medical InnovationsNewsTechnology

Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment

HerinaAyot
HerinaAyot
Share
4 Min Read
SHARE

Avita Medical Limited (ASX: AVH) is a publicly traded global medical technology company trading on the Australian Stock Exchange. It develops, distributes and commercializes regenerative medicine products.

Avita Medical Limited (ASX: AVH) is a publicly traded global medical technology company trading on the Australian Stock Exchange. It develops, distributes and commercializes regenerative medicine products.

Avita’s clinically tested, tissue-engineered product, ReCell, provides revolutionary solutions utilizing the patient’s own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects. Most recently, the company has announced the product’s proven ability to treat chronic leg ulcers.

ReCell is a spray-on, stand-alone rapid cell harvesting device, which enables surgeons to treat skin defects using the patient’s own cells. The product allows for the surgeon to prepare a small quantity of cells within 30 minutes on site. The metabolic cells, then migrate across the surface of the wound, creating regenerative skin of normal color and texture. ReCell has been designed for use in a wide variety of burns, plastic, reconstructive and cosmetic procedures. It can replace the current technique of skin grafting.

More Read

Can Big Data Analytics Make Telemedicine More Functional?
Here’s How IoT In Sports Is Transforming The Field
Predictive Analytics and Data Mining Reduce Healthcare Costs and Improve Outcomes
Helping Patients Quantify Their Health Data: The Quantified Self Movement
Blue Button Mobile Available for Veterans to Download and View Personal Health Records

According to a presentation given by Dr Giuliano Magi, M.D., and colleagues, “Autologous transplantation of epidermal cells is difficult to treat ulcers of the lower limbs.”  Out of 10 patients whom were suffering from unhealed chronic ulcers, 1 was lost due to an unrelated incident, 8 achieved 100% healing and 1 achieved 90% re-epithelialization after a 4 week period.

Dr. Magi stated, “ReCell has demonstrated a very high success rate in the treatment of chronic leg ulcers. Although we have only a limited sample size, the outcomes in these recalcitrant ulcers are clinically outstanding and cost-effective for the healthcare system. Furthermore patients report an immediate decrease in pain and are resuming normal activities straight after the ReCell procedure making it more acceptable to the patients themselves.”

Treating chronic leg ulcers alone is a market estimated at $1 billion. More thank 3,500 patients have been treated with ReCell for injuries such as, burns, hypo and hyper-pigmentation, scarring and wrinkle removal. Over the last year, revenues have increased 29%, and sales have increased about 150%. Management expects this trend to continue, with regenerative products contributing an increasing proportion of sales revenues.

“Sales of our ReCell Spray‐On‐Skin regenerative product have shown strong growth, not only year‐to‐year and quarter‐to‐quarter but also in consecutive quarters,” said William Dolphin, Ph.D., CEO of Avita Medical. “ReCell is an easy-to-use bedside kit that is now available to clinicians in Australia, France, Germany, Portugal, Russia, The Netherlands and the United Kingdom.”

In addition to regenerative treatments, Avita also commercializes medical technologies for improved medication delivery and adherence in patients suffering from chronic respiratory diseases.

Avita Medical Limited will be presenting its products and technologies at OneMedForum SF 2012, on January 9 – 12.

 

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Is Telehealth A Viable Solution To The Dentist Shortage?
Medical DevicesMedical InnovationsTechnology

Is Telehealth A Viable Solution To The Dentist Shortage?

October 5, 2017
Technology

How Do Food Delivery Workers Stay Safe?

September 11, 2019
health care advice
Medical EducationPolicy & LawTechnology

Skate to Where Health Care Is Going, Not to Where It Has Been

August 4, 2013

Big Tobacco is Still Targeting Our Kids

March 23, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?